clinical trial biomarker data analysis software platform for immuno-oncology.
platform with a collection of all published biomarkers in immuno-oncology
platform for exploration of omics data available in The Cancer Genome Atlas
platform for identifying neopeptides using individual patient sequencing data
OMICS-Chart-IO integrates high-dimensional complex molecular data and the most recent scientific research to support the decision-making process in personalized and precision medicine in immuno-oncology, leading to improvements in quality of treatment and outcome for cancer patients.
We provide free access to two submodules of OmicsChart IO:
Browse The Cancer Genome Atlas using our convenint interface, explore matation and expression data, estimation of infiltration by immune cells in solid tumors, or correlate any of the above to each other
Look up any biomarker from published literature, see in which clinical trials it was used, and even upload your own sample to estimate this biomarker and compare it to TCGA samples.
Look up any biomarker from published literature, see in which clinical trials it was used, and even upload your own sample to estimate this biomarker and compare it to TCGA samples.
Browse The Cancer Genome Atlas using our convenint interface, explore matation and expression data, estimation of infiltration by immune cells in solid tumors, or correlate any of the above to each other
Correlate biomarkers to clinical parameters, perform survival analysis and identify early evidence of treatment response.
Compare biomarker values to real-world data from public datasets like TCGA, GTEx and many others - analyze n-of-one and get a bigger picture.
Use our Immuno-Oncology Biomarker Encyclopedia to find and evaluate biomarkers that are relevant for your drug and cancer type
OmicsChart has been accepted as one of 12 participants for Biotech Bootcamp by SmiLe and BioM - a business development program for aspiring biotech entrepreneurs by Europe’s leading biotech incubators.
OmicsChart has been accepted as one of 12 participants for Biotech Bootcamp by SmiLe and BioM - a business development program for aspiring biotech entrepreneurs by Europe’s leading biotech incubators.
OmicsChart has been accepted as one of 12 participants for Biotech Bootcamp by SmiLe and BioM - a business development program for aspiring biotech entrepreneurs by Europe’s leading biotech incubators.
Now we’re still working on this product, please insert your email and will get back to you.
Thank you for your interest in our product. We will contact you shortly.